DeepMed Research

WEST VIRGINIA UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1867-01-01

Employees: 101

Market Cap: -

Website: http://www.wvu.edu

Clinical Trials

Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis

Phase 4

Terminated

Conditions: Cystic Fibrosis

Interventions: Drug: Piperacillin-tazobactam combination product

First Posted Date: 2012-09-26

Last Posted Date: 2022-02-01

Lead Sponsor: West Virginia University

Target Recruit Count: 6

Registration Number: NCT01694069

Locations: 🇺🇸
West Virginia University Healthcare, Morgantown, West Virginia, United States

1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX

Phase 2

Terminated

Conditions: Rash

Interventions: Drug: Pimecrolimus
Drug: Placebo

First Posted Date: 2012-09-25

Last Posted Date: 2017-03-15

Lead Sponsor: West Virginia University

Target Recruit Count: 13

Registration Number: NCT01692626

Locations: 🇺🇸
West Virginia University Hospitals Mary Babb Randolph Cancer Center, Morgantown, West Virginia, United States

Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms

Completed

Conditions: Methicillin-Resistant Staphylococcus Aureus

First Posted Date: 2012-08-23

Last Posted Date: 2015-06-02

Lead Sponsor: West Virginia University

Target Recruit Count: 400

Registration Number: NCT01671358

Locations: 🇺🇸
West Virginia University Hospitals, Morgantown, West Virginia, United States

Home Telemonitoring for Patients With Lung Cancer

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Device: HomMed Telemonitor

First Posted Date: 2012-08-22

Last Posted Date: 2022-10-18

Lead Sponsor: West Virginia University

Target Recruit Count: 47

Registration Number: NCT01670539

Locations: 🇺🇸
WVU Mary Babb Randolph Cancer Center and Ruby Hospital, Morgantown, West Virginia, United States

Effect of Diet and Exercise in Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer
Obesity

First Posted Date: 2011-12-23

Last Posted Date: 2013-10-30

Lead Sponsor: West Virginia University

Target Recruit Count: 28

Registration Number: NCT01498536

Locations: 🇺🇸
West Virginia University, Morgantown, West Virginia, United States

Quit and Fit: Teen Smoking Cessation

Not Applicable

Completed

Conditions: Tobacco Use Cessation

Interventions: Behavioral: Not On Tobacco (N-O-T) Program
Behavioral: Physical Activity Module

First Posted Date: 2010-11-17

Last Posted Date: 2017-11-06

Lead Sponsor: West Virginia University

Target Recruit Count: 236

Registration Number: NCT01242657

Locations: 🇺🇸
West Virginia University, Morgantown, West Virginia, United States

Once Daily Targeted Intravenous (IV) Busulfex as Part of Reduced-toxicity Conditioning for Patients With Refractory Lymphomas Undergoing Allogeneic Transplantation

Phase 2

Completed

Conditions: Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma

Interventions: Drug: Busulfan
Drug: Fludarabine

First Posted Date: 2010-09-16

Last Posted Date: 2023-07-13

Lead Sponsor: West Virginia University

Target Recruit Count: 22

Registration Number: NCT01203020

Locations: 🇺🇸
West Virginia University Hospitals Mary Babb Randolph Cancer Center, Morgantown, West Virginia, United States

Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP)

Completed

Conditions: Acute Myeloid Leukemia

First Posted Date: 2010-09-16

Last Posted Date: 2017-02-07

Lead Sponsor: West Virginia University

Target Recruit Count: 68

Registration Number: NCT01203033

Locations: 🇺🇸
MBRCC, West Virginia University, Morgantown, West Virginia, United States

Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation

Phase 2

Completed

Conditions: Graft vs Host Disease

Interventions: Drug: Atorvastatin calcium (Lipitor)

First Posted Date: 2010-08-04

Last Posted Date: 2017-06-07

Lead Sponsor: West Virginia University

Target Recruit Count: 60

Registration Number: NCT01175148

Locations: 🇺🇸
West Virginia University Hospitals Mary Babb Randolph Cancer Center, Morgantown, West Virginia, United States

OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas

Phase 1

Withdrawn

Conditions: Central Nervous System Tumors

Interventions: Drug: Bevacizumab, CA4P

First Posted Date: 2010-01-20

Last Posted Date: 2017-02-09

Lead Sponsor: West Virginia University

Registration Number: NCT01052363

Locations: 🇺🇸
MBRCC, West Virginia University, Morgantown, West Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy